🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

A Community-based Solution for Nocturia: Integrating Digital Technology and Behavioral Interventions

RecruitingNAAges 55 Years - anyAllNational Taiwan University Hospital
NCT07734207 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

Nocturia is a prevalent and distressing condition among older adults in Taiwan, significantly impacting sleep quality, mental health, and fall risks. This pilot study evaluates a novel community-based management model that integrates digital health technology with behavioral therapy. Participants aged 55 years or older experiencing nocturia (≥2 voids/night) will be cluster-randomized into an intervention group or a control group. The intervention group will utilize a voiding diary and a non-contact home uroflowmetry (HUFM) device to track voiding patterns and receive real-time feedback. This data-driven approach is combined with personalized lifestyle guidance (e.g., fluid restriction and leg elevation) and psychiatric screening for sleep and mood disorders. The primary objective is to evaluate the reduction in nocturnal voids and improve quality of life, while exploring the potential t

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: 1. Baseline nocturia frequency ≥ 2 times/night (confirmed by subjective report or simplified questionnaire). 2. Ability to operate LINE on a smartphone or have a caregiver assist with completing the electronic urinary diary. Exclusion Criteria: 1. Acute urinary tract infection 2. Uncontrolled heart failure 3. Serum sodium \< 130 mEq/L 4. Underwent urological surgery within the past three months 5. Major psychiatric or neurological disorder in an active phase, (GDS-15\>5) 6. Participation in other clinical trials related to nocturia
💊

What it tests

  • Home Uroflowmetry
  • Voiding Diary
📍

Where

1 site
Yunlin HI-HOPE Community Hub
Douliu, Taiwan
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy